Article
First-in-Human Study of a First-in-Class AI-Designed Monoclonal Antibody (GB-0669) Against the Conserved SARS-CoV-2 Spike S2 Stem Helix
2025-10-08
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background</h4> Antibodies against the SARS-CoV-2 spike receptor-binding domain provided effective COVID-19 treatment until resistant variants emerged. GB-0669 is a half-life extended monoclonal antibody optimized using artificial intelligence, targeting the conserved spike S2 stem helix, a region with limited selective pressure from natural infection-or vaccine-induced antibody responses....
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 91bc68b8-9c9b-5549-84ca-4069baed5281
- DOI
- 10.1101/2025.10.07.25337449
